Celldex Therapeutics Inc
(FRA:TCE2)
€
19.6
+0.10 (+0.51%)
Market Cap: 1.28 Bil
Enterprise Value: 704.31 Mil
PE Ratio: 0
PB Ratio: 2.12
GF Score: 59/100 Celldex Therapeutics Inc (FRA:TCE2) Transcripts
- 1